Semaglutide is a synthetic version of a gut hormone your body naturally produces called GLP-1. It’s built on a chain of 31 amino acids, chemically modified with a fatty acid side chain that makes it last far longer in the body than the natural hormone. The peptide backbone is produced by genetically engineered yeast, then chemically altered in a multi-step process to create the final drug found in products like Ozempic, Wegovy, and Rybelsus.
The Peptide Backbone
At its core, semaglutide is a short protein (a peptide) made of 31 amino acids. This sequence closely mirrors the natural GLP-1 hormone that your intestines release after eating, which signals your pancreas to produce insulin and tells your brain you’re full. Natural GLP-1 breaks down in about two minutes in the bloodstream, making it useless as a medication on its own.
To fix that, the makers of semaglutide changed two things in the amino acid chain. First, at position 8, the natural amino acid alanine was swapped for a synthetic one called aminoisobutyric acid. This single substitution makes the peptide resistant to an enzyme (DPP-4) that would otherwise chop it apart within minutes. Second, the amino acid at position 34 was changed to arginine, which helps stabilize the molecule further.
The Fatty Acid Side Chain
The most important engineering trick in semaglutide is an 18-carbon fatty acid chain (called a C-18 diacid) attached to the amino acid lysine at position 26. This side chain is connected through a small linker made of a glutamic acid spacer and two short segments of polyethylene glycol, a common molecule used in pharmaceuticals to improve drug stability.
This fatty acid chain is what gives semaglutide its remarkably long half-life of about seven days, compared to the two-minute lifespan of natural GLP-1. The chain works by grabbing onto albumin, the most abundant protein in your blood. Once bound to albumin, the semaglutide molecule is essentially riding through your bloodstream on a much larger carrier. This does three things: it slows how quickly your kidneys filter out the drug, it shields the peptide from being broken down by enzymes, and it creates a slow-release effect as semaglutide gradually detaches from albumin to do its work. That seven-day half-life is what makes once-weekly injections possible.
For comparison, an older drug in the same class, liraglutide, uses a shorter C-16 fatty acid chain. Semaglutide’s longer C-18 chain binds more tightly to albumin, which is one reason semaglutide lasts long enough for weekly dosing while liraglutide requires daily injections.
How the Peptide Is Manufactured
Semaglutide isn’t assembled entirely in a lab from scratch. The peptide backbone is produced biologically using genetically modified baker’s yeast (Saccharomyces cerevisiae). Scientists insert DNA instructions into the yeast cells, which then grow in fermentation tanks and produce a precursor version of the semaglutide peptide.
After fermentation, that precursor goes through several rounds of recovery, isolation, and purification. Then comes a critical chemical step: the purified peptide is acylated, meaning the C-18 fatty acid chain and its linker are chemically attached to the lysine at position 26. Finally, a two-amino-acid fragment is joined to the front end of the chain to complete the full 31-amino-acid sequence. The FDA has described this manufacturing process as complex, involving multiple production steps that are difficult to replicate outside of specialized pharmaceutical facilities.
Inactive Ingredients in the Injection
The semaglutide molecule itself is only one component of what’s in the pen or vial. The injectable formulations (Ozempic and Wegovy) contain a simple set of inactive ingredients per milliliter of solution: 1.42 mg of disodium phosphate dihydrate (a buffer that keeps the pH stable), 8.25 mg of sodium chloride (salt, which makes the solution compatible with your body’s tissues), and sterile water. The solution is adjusted to a pH of about 7.4, which matches the pH of your blood, using tiny amounts of hydrochloric acid or sodium hydroxide. There are no preservatives like phenol or metacresol in Wegovy’s formulation, which is one reason the prefilled pens are designed for single use.
What Makes the Oral Version Different
The oral tablet form of semaglutide (sold as Rybelsus, and also available as a tablet version of Wegovy) contains the same active molecule but faces a completely different challenge: surviving your stomach. Proteins are normally destroyed by stomach acid and digestive enzymes long before they can be absorbed, which is why most peptide drugs are injected.
To solve this, the tablets include an absorption enhancer called salcaprozate sodium, or SNAC. This compound is a small fatty acid derivative that does two things at once. It temporarily increases the permeability of the stomach lining, creating a brief window for semaglutide molecules to pass through into the bloodstream. It also lowers the pH in the immediate area around the tablet, creating a micro-environment that protects semaglutide from being broken down by digestive enzymes. This absorption is size-selective, meaning it preferentially lets smaller molecules like semaglutide through while keeping larger ones out. The only other inactive ingredient in the tablet is magnesium stearate, a standard filler used in pills.
Even with SNAC, oral absorption is relatively inefficient, which is why the tablets need to be taken on an empty stomach with no more than four ounces of plain water, and you need to wait at least 30 minutes before eating or drinking anything else.
Why the Composition Matters
Every structural choice in semaglutide’s design solves a specific problem. The amino acid swap at position 8 prevents rapid enzymatic breakdown. The fatty acid chain at position 26 extends the drug’s life from minutes to a full week. The yeast-based manufacturing ensures consistent, large-scale production of a complex biological molecule. And the SNAC in the oral version makes the seemingly impossible (absorbing a protein through the gut) just barely possible enough to work as a daily pill. Together, these components turn a fragile, short-lived natural hormone into a stable pharmaceutical that has become one of the most widely prescribed medications in the world.